Director, CMC Regulatory Affairs
Leads global CMC regulatory strategy for small molecule medicines, working across R&D, supply, quality, and commercial functions to ensure regulatory compliance and uninterrupted patient supply. Provides strategic direction on regulatory submissions, mentors regulatory staff, and engages with global authorities. Focuses on solving complex regulatory challenges while aligning with business objectives and patient impact.